Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Maintenance in Essential Thrombocythemia
NCT02611973Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2016
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in essential thrombocythemia (ET), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
aspirin
03
Conditions
essential thrombocythemia (ET)
Beyond the preview
Go deeper on NCT02611973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02611973.